Since 2016, the FDA has received 25 reports of unapproved epinephrine nasal solution being confused with approved epinephrine injection.
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback